Neurocrine Biosciences, Inc. (NBIX)
140.92
-2.72
(-1.89%)
USD |
NASDAQ |
Dec 30, 16:00
140.92
0.00 (0.00%)
After-Hours: 18:26
Neurocrine Biosciences Market Cap: 14.05B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 142.11B |
| Masimo Corp. | 7.040B |
| Insulet Corp. | 20.19B |
| Marker Therapeutics, Inc. | 24.84M |
| CapsoVision, Inc. | 576.64M |
Market Cap Related Metrics
| PE Ratio | 33.65 |
| PS Ratio | 5.370 |
| PEG Ratio | 2.764 |
| Price to Book Value | 4.678 |
| Price to Free Cash Flow | 24.29 |
| Price | 140.92 |
| Earnings Yield | 2.97% |
| PEGY Ratio | 2.764 |
| Operating PE Ratio | 26.02 |
| Normalized PE Ratio | 33.00 |